At the news
? MIXEDIMPACT 5/10 8-K filed Jun 12, 2026 at 09:09 ET
BiomX Inc. received acceptance from NYSE American of its plan to regain compliance with continued listing standards, granting a plan period through September 25, 2027. The company had a stockholders' deficit of $(1.302 million) as of December 31, 2025 and losses in five recent fiscal years, leading to its non-compliance. While the plan acceptance provides a path to avoid delisting, the underlying financial weakness and high execution risk keep the outlook uncertain.
- NYSE American accepted BiomX's compliance plan on June 10, 2026, with a plan period through September 25, 2027.
- Non-compliance stemmed from stockholders' deficit of $1.302 million as of Dec 31, 2025 and losses from continuing operations in five recent fiscal years.
- The company's stock will continue trading with a .BC (below compliance) indicator during the plan period.
- If the company fails to regain compliance or make sufficient progress, delisting proceedings may be initiated.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access